Interleukin Genetics Reports Second Quarter 2009 Financi...(target'_new' target'_new' target'_new' h...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Interleukin Genetics Reports Second Quarter 2009 Financial Results
Date:8/13/2009
target='_new' target='_new' target='_new' href='http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=ILI'> ILI) develops and markets genetic tests that empower consumers to prevent chronic diseases of aging and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property, and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics is headquartered in Waltham, MA. For more information please visit www.ilgenetics.com.
Certain statements contained herein are "forward-looking" statements including statements regarding growth of the Company's genetic testing business and the Company's ability to achieve compliance with the NYSE Amex continued listing standards by December 31, 2009. Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the risk of market acceptance of the Company's products, the risk of technology and product obsolescence, delays in product development, the performance of commercial partners, the availability of adequate capital, the actions of competitors and other competitive risks, and those risks and uncertainties described in the Company's annual report on Form 10-K for the year ended December 31, 2008, quarterly reports on Form 10-Q and other filings with the Securities and Exchange Commission. The Company disclaims any obligation or intention to update these forward-
'/>"/>
| SOURCE Interleukin Genetics, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
2. Interleukin Genetics to Present at the 2009 BIO Business Forum
3. Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
4. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
5. Interleukin Genetics Appoints Todd Anthony Walker as Vice President, Marketing
6. Interleukin Genetics Reports Third Quarter 2008 Financial Results
7. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
8. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
9. Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
10. Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results
Post Your Comments:
Breaking Biology Technology:BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 2BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 3BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines 4Metamaterials could reduce friction in nanomachines 2Metamaterials could reduce friction in nanomachines 3Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2
Other Biology Technology:Sweet nanotech batteries 2Vermillion Announces Appointment of John Hamilton to Board of Directors 2SPO Medical to Conduct Live Investor Meeting on April 29, 2008 2SPO Medical to Conduct Live Investor Meeting on April 29, 2008 3
Breaking Biology News(10 mins):IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2New York autopsies show 2009 H1N1 influenza virus damages entire airway 2New York autopsies show 2009 H1N1 influenza virus damages entire airway 3AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 2Nationwide Heat Wave Finally Gives Way To Cooling Trend 50625 1Nationwide Heat Wave Finally Gives Way To Cooling Trend 50625 2Nationwide Heat Wave Finally Gives Way To Cooling Trend 50625 3Winner Medical Signs PurCotton Sales Agreement With Consumer Products Leader in China 50622 1Winner Medical Signs PurCotton Sales Agreement With Consumer Products Leader in China 50622 2Winner Medical Signs PurCotton Sales Agreement With Consumer Products Leader in China 50622 3Its Time to Clean Up This Mess 3A Texas Surgeon Points Out Numerous Flaws in American Health Care Industry 50619 1Its Time to Clean Up This Mess 3A Texas Surgeon Points Out Numerous Flaws in American Health Care Industry 50619 2
Other Biology News:Gene panel predicts lung cancer survival, study finds 2American Chemical Society's Weekly PressPac -- July 16, 2008 2American Chemical Society's Weekly PressPac -- July 16, 2008 3American Chemical Society's Weekly PressPac -- July 16, 2008 4American Chemical Society's Weekly PressPac -- July 16, 2008 5American Chemical Society's Weekly PressPac -- July 16, 2008 6American Chemical Society's Weekly PressPac -- July 16, 2008 7American Chemical Society's Weekly PressPac -- July 16, 2008 8American Chemical Society's Weekly PressPac -- July 16, 2008 9End in sight for the dreaded dentist drill 2
Biology Products:
Mouse Anti-Human Non-SMC condensin II complex, subunit D3 (NCAPD3) Monoclonal Antibody, Unconjugated from Lifespan BiosciencesTSQ Quantum Ultra AM from Thermo ScientificCORNING 1536 WELL PLATE,2UL,BLACK,NON-TREATED,NON STERILE from Sigma-AldrichIncubator with Reciprocal Shaker and Rotisserie from Major Science
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |